Rapport Therapeutics Inc (RAPP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RAPP | NEO | AAPG | ||
| Company | Rapport Therapeutics Inc | Neogenomics Inc | Ascentage Pharma Group Intl ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 39.28 | 14.65 | 19.25 | ||
| High | 41.29 | 15.04 | 19.25 | ||
| Low | 39.28 | 14.61 | 18.60 | ||
| Latest | 42.14 | 14.89 | 18.60 | ||
| Change | +2.01 | +0.05 | -1.80 | ||
| % Change | +5.01% | +0.34% | -8.82% | ||
| Volume | 33,563 | 316,616 | 10,000 | ||
| 20-Day Average Volume | 465,964 | 3,220,960 | 18,491 | ||
| Previous Close | 40.13 | 14.84 | 20.40 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 40.05 | 13.95 | 18.39 | ||
| 20-Day Raw Stochastic | 63.56% | 88.08% | 57.92% | ||
| 20-Day Relative Strength | 56.08 | 69.23 | 47.81 | ||
| Weighted Alpha | +102.22 | +109.17 | -53.56 | ||
| Today's Opinion | 100% Buy | 88% Buy | 72% Sell | ||
| Previous Opinion | 100% Buy | 88% Buy | 56% Sell | ||
| Last Month's Opinion | 100% Buy | 40% Buy | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.56% since 07/10/26 | +6.13% since 07/10/26 | -6.36% since 07/10/26 | ||
| Low | 38.62 on 07/16/26 | 13.80 on 07/14/26 | 18.70 on 07/17/26 | ||
| High | 42.65 on 07/13/26 | 15.03 on 07/17/26 | 20.40 on 07/16/26 | ||
| 1-Month | |||||
| %Chg | +11.47% since 06/17/26 | +44.27% since 06/17/26 | +9.42% since 06/17/26 | ||
| Low | 36.46 on 06/18/26 | 10.58 on 06/18/26 | 16.36 on 06/26/26 | ||
| High | 43.76 on 06/30/26 | 15.57 on 07/06/26 | 20.40 on 07/16/26 | ||
| 3-Month | |||||
| %Chg | +3.50% since 04/17/26 | +79.34% since 04/17/26 | -31.75% since 04/17/26 | ||
| Low | 32.41 on 04/30/26 | 7.69 on 04/23/26 | 16.36 on 06/26/26 | ||
| High | 43.76 on 06/30/26 | 15.57 on 07/06/26 | 26.72 on 04/21/26 | ||
| 6-Month | |||||
| %Chg | +53.30% since 01/16/26 | +17.08% since 01/16/26 | -30.87% since 01/16/26 | ||
| Low | 25.21 on 02/05/26 | 7.07 on 03/30/26 | 16.36 on 06/26/26 | ||
| High | 43.76 on 06/30/26 | 15.57 on 07/06/26 | 28.06 on 04/06/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,919,297 | 1,932,346 | 1,905,136 | ||
| Shares Outstanding, K | 47,827 | 130,212 | 93,389 | ||
| Annual Sales | 0 | 727,330,000 | 82,100,000 | ||
| Annual Net Income | -111,480,000 | -108,030,000 | -177,710,000 | ||
| Last Quarter Sales | 20,000,000 | 186,670,000 | N/A | ||
| Last Quarter Net Income | -19,860,000 | -17,110,000 | N/A | ||
| 60-Month Beta | 0.94 | 1.74 | 0.09 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.42 on 05/07/26 | 0.01 on 04/28/26 | N/A | ||
| Earnings Date | 08/06/26 | 07/28/26 | 03/25/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||